0
Summaries for Patients |

Chemotherapy in Women with Breast Cancer FREE

[+] Article and Author Information

The summary below is from the full report titled “Discrepancy between Consensus Recommendations and Actual Community Use of Adjuvant Chemotherapy in Women with Breast Cancer.” It is in the 21 January 2003 issue of Annals of Internal Medicine (volume 138, pages 90-97). The authors are XL Du, CR Key, C Osborne, JD Mahnken, and JS Goodwin.


Ann Intern Med. 2003;138(2):I-16. doi:10.7326/0003-4819-138-2-200301210-00002
Text Size: A A A

What is the problem and what is known about it so far?

After surgery to remove breast cancer, patients frequently receive chemotherapy. Chemotherapy after surgery is known as adjuvant chemotherapy. An increasing number of studies show that women with early breast cancer do better if they receive adjuvant chemotherapy rather than surgery alone. The National Institutes of Health (NIH) periodically convenes expert panels to review evidence about which women with breast cancer are most likely to benefit from adjuvant chemotherapy, and it issues reports known as consensus statements. The NIH recommends adjuvant chemotherapy for all women whose breast cancer has spread to lymph nodes and for all women who have a tumor larger than 1 cm in size. These recommendations apply to postmenopausal women and to women in whom the tumor has chemical markers indicating that hormones can control tumor growth rate. Little is known about how closely doctors follow these recommendations.

Why did the researchers do this particular study?

The researchers wanted to find out whether the NIH consensus panel recommendations were being followed and whether a patient's age affects use of adjuvant chemotherapy.

Who was studied?

More than 5000 women with early-stage breast cancer who were 20 years of age or older (range, 20 to 98 years). All women were entered into the New Mexico Tumor Registry from 1991 to 1997.

How was the study done?

The researchers performed a computer analysis of data in the Registry to answer three questions: 1) What percentage of women with breast cancer received adjuvant chemotherapy? 2) For each age group [measured in 5-year intervals], what were the chances that chemotherapy was being administered? and 3) Do factors other than patient age affect chemotherapy use?

What did the researchers find?

Overall, 29% of the entire study group received adjuvant chemotherapy. The older a woman was, the less likely she was to receive adjuvant chemotherapy. Specifically, 66% of women younger than 45 years of age, 44% of women age 50 to 54 years, 31% of women age 55 to 59 years, 18% of women age 60 to 64 years, 12% of women age 65 to 69 years, and 3% of women older than age 75 years received adjuvant chemotherapy. The researchers could not detect any other factors that explained why older women were less likely than younger women to receive chemotherapy.

What were the limitations of the study?

The researchers could not be sure that all cases of breast cancer were being reported to the Registry. Also, they did not have any information on whether the patients who received adjuvant chemotherapy actually did any better than those who did not.

What are the implications of the study?

The NIH consensus panel recommendations are not being followed in most women with early-stage breast cancer, especially women older than 45 years of age. The reasons for this failure to treat are not clear, but doctors may be missing the opportunity to treat many women with early-stage breast cancer more effectively.

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Related Point of Care
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)